Funds and ETFs Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra 11:43:10 2024-05-24 am EDT 5-day change 1st Jan Change
27.63 EUR +0.16% Intraday chart for Bayer AG -3.32% -17.84%

ETFs positioned on Bayer AG

Name Weight AuM 1st Jan change Investor Rating
9.77% 70 M€ -.--% -
5.71% 2 M€ +13.56% -
4.28% 962 M€ -.--% -
4.10% 0 M€ 0.00% -
3.33% 18 M€ +7.68%
3.03% 79 M€ -.--%
1.91% 131 M€ -.--% -
1.63% 264 M€ +13.50% -
1.52% 17 M€ +7.15% -
0.79% 6 M€ -.--% -
0.72% 17 M€ 0.00%
0.53% 6 M€ -.--%
0.42% 1,083 M€ +4.23%
0.31% 7 M€ +5.87% -
0.30% 10 M€ -3.35% -
0.28% 75 M€ +7.00% -
0.21% 32 M€ +1.29% -
0.18% 32 M€ +7.50% -
0.14% 29 M€ +8.37% -
0.13% 283 M€ +21.92%
0.09% 607 M€ +0.05% -
0.09% 1,166 M€ +0.26% -
0.09% 0 M€ 0.00% -
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
27.63 EUR
Average target price
36.9 EUR
Spread / Average Target
+33.57%
Consensus
  1. Stock Market
  2. Equities
  3. BAYN Stock
  4. Funds and ETFs Bayer AG